Propafenone--a new antiarrhythmic agent. Clinical experience
Kozák, P.; Stárek, A.; Hes, I.; Spacek, R.
Casopis Lekaru Ceskych 124(13): 407-410
1985
ISSN/ISBN: 0008-7335 PMID: 3891090 Document Number: 256692
Document emailed within 1 workday
Related Documents
Jazwinska-Tarnawska, E.; Orzechowska-Juzwenko, K.; Niewinski, P.; Rzemislawska, Z.; Loboz-Grudzien, K.; Dmochowska-Perz, M.; Slawin, J. 2001: The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment International Journal of Clinical Pharmacology and Therapeutics 39(7): 288-292Li, Z.S. 1987: Antiarrhythmic effect and blood levels of propafenone Zhonghua Xin Xue Guan Bing Za Zhi 15(1): 31-33
Wascher, T.C.; Dittrich, P.; Kukovetz, W.R. 1991: Antiarrhythmic effects of two new propafenone related drugs. a study on four animal models of arrhythmia Arzneimittel-Forschung 41(2): 119-124
Beck, O.A.; Witt, E.; Hochrein, H. 1975: Effect of the antiarrhythmic agent propaphenone on cardiac conduction. clinical studies using bundle of his electrography Zeitschrift für Kardiologie 64(2): 179-187
Beck, O.A.; Vogt, J.; Hochrein, H. 1978: The comparative hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction (comparison of propafenone and lidocaine) Zeitschrift für Kardiologie 67(1): 41-45
Frandsen, F.; Pless, P.; Mickley, H.; Møller, M. 1990: Antiarrhythmic treatment with flecainide (Tambocor). Clinical experience from 107 patients Acta Cardiologica 45(5): 351-357
Sloskey, G.E. 1983: Amiodarone: a unique antiarrhythmic agent Clinical Pharmacy 2(4): 330-340
Borkowski, P.J. 1970: Bretylium tosylate as an antiarrhythmic agent Kardiologia Polska 13(2): 195-198
Laskawiec, G.; Zmudziński, J.; Jamrozik-Kruk, Z. 1993: Bepridil--a new antianginal agent with antiarrhythmic properties Polski Tygodnik Lekarski 48(14-15): 330-332
Dvorák, K.; Vavros, B.; Cerný, J. 1975: Bretylium tosylate--a new antiarrhythmic agent with antifibrillatory effect Vnitrni Lekarstvi 21(3): 278-284
Gülker, H.; Thale, J.; Olbing, B.; Heuer, H.; Frenking, B.; Bender, F. 1985: Assessment of the antiarrhythmic profile of the new class i agent diprafenone Arzneimittel-Forschung 35(9): 1387-1393
Ser, I. 1971: Clinical experience with glibenclamide, a new hypoglycemic agent Harefuah 81(8): 364-368
Lindstrom, T.D.; Lacefield, W.B.; Whitaker, G.W. 1984: Metabolism of the antiarrhythmic agent, indecainide, in rats, dogs, and monkeys Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(6): 691-697
Fellner, R.; Simon, A. 1973: Clinical experience with a new vasotherapeutic agent in diseases of the fundus Klinische Monatsblatter für Augenheilkunde 162(6): 811-817
Karapetian, A.E.; Gevorkian, R.A. 1972: Action of 4-methyluracil as an antiarrhythmic agent stimulating the growth of myocardial cells Farmakologiia i Toksikologiia 35(3): 297-299
Rodríguez-Miñón, J.L.; Herrera Pombo, J.L.; Marrón, J.A. 1971: Clinical experience with RO 6-4563 (Glibornuride) (a new oral hypoglycemic agent) Revista Clinica Espanola 123(5): 439-442
Haspels, A.A. 1983: Clinical experience with a low-dose contraceptive agent. European studies Journal of Reproductive Medicine 28(1 Suppl): 71-76
Valkó, I.; Szepesi, G. 1990: An improved TLC method for investigation of the metabolic profile of BGYKI-38233--a new antiarrhythmic agent Die Pharmazie 45(4): 290
Cheng, Y.N.; Kiyosue, T.; Arita, M. 1994: Effects of KT-362, a new antiarrhythmic agent, on membrane ionic currents of guinea pig ventricular myocytes Journal of Pharmacology and Experimental Therapeutics 270(3): 851-857
Varma, Y.S.; Sharma, P.L. 1971: Clinical experience with pancuronium bromide (NA97): a new steroid neuromuscular blocking agent Indian Journal of Medical Research 59(1): 69-75